Skip to content

COMPARISON OF TAMSULOSIN AND SILODOSIN IN TREATMENT OF LOWER URETERIC STONES

COMPARISON OF EFFICIENCY OF TAMSULOSIN VS SILODOSIN IN THE TREATMENT OF LOWER URETERIC CALCULUS-RANDOMISED CONTROLLED STUDY

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/019961
Enrollment
120
Registered
2019-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N201- Calculus of ureter

Interventions

Intervention1: SILODOSIN: SILODOSIN 8mg HS orally till expulsion of calculus or a maximum period of 30 days Control Intervention1: TAMSULOSIN: TAMSULOSIN 0.4mg HS orally till expulsion of calculus or

Sponsors

ARUNCHAND R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Unilateral distal ureteric calculus b) Size c) Normal renal parameters (Serum Urea & Serum Creatinine) d) Age 18-60 yrs

Exclusion criteria

Exclusion criteria: a) Single kidney b) Bilateral ureteric stone c) Mid/upper ureteric calculus d) Renal impairment e) High grade hydroureteronephrosis (Grade III & IV as per Society of Fetal Ultrasound, SFU) f) Any h/o previous endoscopic/ surgical/ ESWL interventions g) Intolerable side-effects (Hypotension) to either tamsulosin/ silodosin h) Evidence of UTI j) Concomitant kidney/bladder stones k) Patients already on any alpha blocker for BPH

Design outcomes

Primary

MeasureTime frame
STONE CLEARENCE RATE (%)Timepoint: 1. Passing of stone 2. 04 weeks elapsed and surgical intervention planned 3. Symptoms of patient demanding interventional procedures

Secondary

MeasureTime frame
STONE EXPULSION TIME (DAYS)Timepoint: 1. Passing of stone 2. 04 weeks elapsed and surgical intervention planned 3. Symptoms of patient demanding interventional procedures

Countries

India

Contacts

Public ContactArunchand R

Armed Forces Medical College

anurakshat@rediffmail.com9453507975

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026